He was the founder and undoubtedly still involved with the science. He obviously wasn't in the lab every day, but I can't imagine a doctor who founded his own pharma company just completely let that side of the business go to sit in board meetings all day.
I'm not saying HB was going to get the product to market any faster, but he was planning on continuing with the pipeline development in a way I don't think a non-scientist CEO can. In other words short term buy out is the only reasonable path now. Trying to go it alone long term now will only get us outpaced - more so than we were before I feel.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.